Inside Labiotech 30 Nov 2017
Why is Erik Digman Wiklund, CFO of Targovax, reading Labiotech.eu?
Leaders & Readers: I had a chat with Erik Digman Wiklund about why he reads Labiotech.eu. He is the CFO of Targovax, a clinical-stage company focusing on the development of immuno-oncology therapies. This interview has just been lightly edited for grammar. Why do you read Labiotech.eu? I enjoy the easygoing and fun style of Labiotech, which […]